Color Doppler ultrasound in the biopsy-based diagnosis of prostate cancer

A new report from an Italian clinical research team, and based on a randomized clinical trial of 300 patients, suggests that color Doppler ultrasound offers no significant benefit over standard “gray-scale” ultrasound in the biopsy-based diagnosis of prostate cancer — which is not going to please the advocates of color Doppler ultrasonography. … READ MORE …

Color Doppler ultrasound and prostate cancer biopsy

Here in the USA there has been a nucleus of physicians who have argued for years that the use of color Doppler ultrasound enhances the ability to identify and biopsy prostate cancer. New data from Germany are relevant to this conversation. … READ MORE …

Prostate cancer news reports: Wednesday, November 25, 2009

There have been a number of interesting reports over the past couple of days that are summarized briefly below. They encompass such topics as:

  • The validity of the Epstein criteria in predicting clinically indolent prostate cancer
  • MRI and MRSI in patient work-up prior to treatment for stage T1c disease
  • Contrast-enhanced, color Döppler ultrasound and prostate biopsy
  • Gleason scores and cancer “laterality” on biopsy and after surgery
  • Accuracy of prediction of “unilateral” prostate cancer, and implications for focal surgery
  • Patient age and probability of indolent disease
  • Testosterone levels, comorbidities, ADT, and mortality
  • A new “prostate mechanical imaging system” … READ MORE …